Wordt geladen...
Clinical Pharmacokinetics of Upadacitinib: Review of Data Relevant to the Rheumatoid Arthritis Indication
Upadacitinib is a Janus kinase 1 inhibitor developed for treatment of moderate to severe rheumatoid arthritis (RA) and was recently approved by the US Food and Drug Administration for this indication in adults who have had an inadequate response or intolerance to methotrexate. Upadacitinib is curren...
Bewaard in:
| Gepubliceerd in: | Clin Pharmacokinet |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217812/ https://ncbi.nlm.nih.gov/pubmed/31867699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00855-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|